Butalbital/aspirin/caffeine: Difference between revisions
| Line 52: | Line 52: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALAGESIC LQ (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE) SYRUP [POLY PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e98984a9-a06f-47e7-aff1-a757edf9e2be | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ALAGESIC LQ (BUTALBITAL, ACETAMINOPHEN AND CAFFEINE) SYRUP [POLY PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e98984a9-a06f-47e7-aff1-a757edf9e2be | publisher = | date = | accessdate = }}</ref> | ||
<ref>{{Cite web | last = | first = | title = BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE) TABLET [QUALITEST PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aedc5167-cc3c-4044-87fa-4ed648c9f23f | publisher = | date = | accessdate = }}</ref> Normal 0 false false false EN-US X-NONE X-NONE | |||
==References== | ==References== | ||
Revision as of 23:47, 11 February 2014
| Butalbital/aspirin/caffeine |
|---|
| BUTALBITAL, ASPIRIN AND CAFFEINE TABLETS bultabital, aspirin and caffeine tablet ® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Butalbital/aspirin/caffeine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Butalbital/aspirin/caffeine, click here.
Synonyms / Brand Names: ®,
Overview
Category
FDA Package Insert
ALAGESIC LQ (butalbital, acetaminophen and caffeine) syrup Normal 0 false false false EN-US X-NONE X-NONE
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital, acetaminophen, and caffeine) tablet
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
[1] [2] Normal 0 false false false EN-US X-NONE X-NONE